Zeyang Ji

Zeyang Ji

Auto-generated profile, based on publicly available information

Zeyang Ji

Division of Life Science, State Key Laboratory of Molecular Neuroscience, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, China

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 November 2012 in Catalysis Science & Technology
Verified
Journal Article
Closed access
PDF file
Xiaojiang YaoXiaojiang Yao
Xiaojiang Yao
CTChangjin Tang
Changjin Tang
ZJZeyang Ji
Zeyang Ji
YDYue Dai
Yue Dai
YCYuan Cao
Yuan Cao
YCYi Chen
Yi Chen
NO removal by CO model reaction was investigated over a series of ceria-containing solid solutions, prepared by an inverse co-precipitation method, to explore the relationship between the physicochemical properties and catalytic performances of these catalysts. The synthesized samples were studied in detail by means of XRD, Raman, TEM, UV-Vis spectroscopy, N2-physisorption, H2-TPR, OSC, XPS and in situ FT-IR technologies. These results indicate that the incorporation of Zr4+, Ti4+ and Sn4+ into the lattice of CeO2 leads to a smaller grain size and enhanced reduction behavior. Furthermore, the catalytic performance test shows that the activities and selectivities of these solid solutions are higher than pure CeO2 and that the Sn4+-doped sample shows the best results. The reason may be that: (1) the decrease in grain size results in an enlargement of the BET specific surface area and an increase of surface Ce3+. The former is conducive for sufficient contact between the catalyst and reactant molecules and the latter contributes to the adsorption of COx species; (2) the enhanced reduction behavior is beneficial in generating more surface oxygen vacancies during the reaction process, which can weaken the N–O bond to promote the dissociation of NOx effectively. Finally, in order to further understand the nature of the catalytic performances for these samples, a possible reaction mechanism is tentatively proposed.

26 July 2013 in ACS Catalysis
Verified
Journal Article
Closed access
LLLichen Liu
Lichen Liu
ZJZeyang Ji
Zeyang Ji
WZWeixin Zou
Weixin Zou
XGXianrui Gu
Xianrui Gu
YDYu Deng
Yu Deng
LDLin Dong
Lin Dong

1 February 2013 in Applied Catalysis B: Environment and Energy
Verified
Journal Article
Closed access
Xiaojiang YaoXiaojiang Yao
Xiaojiang Yao
QYQiang Yu
Qiang Yu
ZJZeyang Ji
Zeyang Ji
YLYuanyuan Lv
Yuanyuan Lv
YCYuan Cao
Yuan Cao
YCYi Chen
Yi Chen

21 August 2013 in The Journal of Physical Chemistry C
Verified
Journal Article
Closed access
LLLichen Liu
Lichen Liu
XGXianrui Gu
Xianrui Gu
ZJZeyang Ji
Zeyang Ji
WZWeixin Zou
Weixin Zou
CTChangjin Tang
Changjin Tang
LDLin Dong
Lin Dong

1 February 2019 in Cell Reports
Verified
Journal Article
Open access
ZJZeyang Ji
Zeyang Ji
HLHao Li
Hao Li
ZYZhou Yang
Zhou Yang
XHXian Huang
Xian Huang
XKXiao Ke
Xiao Ke
MZMingjie Zhang
Mingjie Zhang
Kibra is a synaptic scaffold protein regulating learning and memory. Alterations of Kibra-encoding gene WWC1 cause various neuronal disorders, including Alzheimer's disease and Tourette syndrome. However, the molecular mechanism underlying Kibra's function in neurons is poorly understood. Here we discover that Kibra, via its N-terminal WW12 tandem domains, binds to a postsynaptic density enriched protein, Dendrin, with a nanomolar dissociation constant. On the basis of the structure of Kibra WW12 in complex with Dendrin PY motifs, we developed a potent peptide inhibitor capable of specifically blocking the binding between Kibra and Dendrin in neurons. Systematic administration of the inhibitory peptide attenuated excitatory synaptic transmission, completely blocked long-term potentiation induction, and impaired spatial learning and memory. A Kibra mutation found in Tourette syndrome patients causes defects in binding to Dendrin. Thus, Kibra can modulate spatial learning and memory via binding to Dendrin.

13 July 2018 in Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
PDF file
Zhuangfeng WengZhuangfeng Weng
Zhuangfeng Weng
YSYuan Shang
Yuan Shang
ZJZeyang Ji
Zeyang Ji
FYFei Ye
Fei Ye
LLLin Lin
Lin Lin
JZJinwei Zhu
Jinwei Zhu
Background: The slit diaphragm is a specialized adhesion junction between opposing podocytes, establishing the final filtration barrier that prevents passage of proteins from the capillary lumen into the urinary space. Nephrin, the key structural and signaling adhesion molecule expressed in the slit diaphragm, contains an evolutionally conserved, atypical PDZ-binding motif (PBM) reported to bind to a variety of proteins in the slit diaphragm. Several mutations in NPHS1 (the gene encoding nephrin) that result in nephrin lacking an intact PBM are associated with glomerular diseases. However, the molecular basis of nephrin-PBM–mediated protein complexes is still unclear. Methods: Using a combination of biochemic, biophysic, and cell biologic approaches, we systematically investigated the interactions between nephrin-PBM and PDZ domain–containing proteins in the slit diaphragm. Results: We found that nephrin-PBM specifically binds to one member of the membrane-associated guanylate kinase family of scaffolding proteins, MAGI1, but not to another, MAGI2. The complex structure of MAGI1-PDZ3/nephrin-PBM reveals that the Gly at the −3 position of nephrin-PBM is the determining feature for MAGI1-PDZ3 recognition, which sharply contrasts with the typical PDZ/PBM binding mode. A single gain-of-function mutation within MAGI2 enabled nephrin-PBM binding. In addition, using our structural analysis, we developed a highly efficient inhibitory peptide capable of specifically blocking the nephrin/MAGI1 interaction. Conclusions: MAGI1 interacts with nephrin-PBM with exquisite specificity. A newly developed, potent inhibitory peptide that blocks this interaction may be useful for future functional investigations in vivo. Our findings also provide possible explanations for the diseases caused by NPHS1 mutations.